Cardiovascular Disease

Experts from the fields of diabetes, cardiorenal and metabolic disease, and obesity will discuss new research and present practice recommendations at the 19th World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease.

Abbott released a white paper outlining the findings of its global market research initiative, Beyond Intervention, designed to assess the vascular patient experience from the perspectives of patients, physicians and health care leaders.

Adults in South Korea with diabetes had a higher risk for cardiovascular disease, coronary heart disease and peripheral arterial disease if they had low appendicular skeletal muscle mass and low grip strength, according to study data.

New data published in the Journal of the American Heart Association found that current smoking was associated with fatal events caused by MI and stroke as first clinical CVD manifestations.

The “strong associations” of urine-to-plasma ratios with cardiovascular mortality implies a connection between renal clearance of uremic solutes and CVD pathogenesis, according to a speaker from ASN Kidney Week.

Among patients with rheumatoid arthritis, 30 days of glucocorticoid use in 6 months is associated with 15% increased odds of major adverse cardiac events in the next 6 months, according to data presented at ACR Convergence 2021.

Increased exposure to air pollution may lead to higher risk for myocardial fibrosis in patients with chronic kidney disease, according to a speaker at ASN Kidney Week.

Tofacitinib is associated with a numerically higher incidence of major adverse cardiac events, versus TNF inhibitors, in patients with rheumatoid arthritis at an increased cardiac risk, according to data presented at ACR Convergence 2021.

Adults with nonalcoholic steatohepatitis and obesity have a much lower risk for a major adverse liver outcome or major adverse cardiovascular event if they undergo bariatric surgery vs. nonsurgical treatment, according to study data.

Pediatric obesity is a complex and serious public threat that continues to grow in prevalence. According to the CDC, childhood obesity affects 12.7 million infants, children and adolescents aged 2 to 19 years.